Abstract
Exosomes
are
well-known
key
mediators
of
intercellular
communication
and
contribute
to
various
physiological
pathological
processes.
Their
biogenesis
involves
four
steps,
including
cargo
sorting,
MVB
formation
maturation,
transport
MVBs,
fusion
with
the
plasma
membrane.
Each
process
is
modulated
through
competition
or
coordination
multiple
mechanisms,
whereby
diverse
repertoires
molecular
cargos
sorted
into
distinct
subpopulations
exosomes,
resulting
in
high
heterogeneity
exosomes.
Intriguingly,
cancer
cells
exploit
strategies,
such
as
aberrant
gene
expression,
posttranslational
modifications,
altered
signaling
pathways,
regulate
biogenesis,
composition,
eventually
functions
exosomes
promote
progression.
Therefore,
exosome
biogenesis-targeted
therapy
being
actively
explored.
In
this
review,
we
systematically
summarize
recent
progress
understanding
machinery
how
it
regulated
context
cancer.
particular,
highlight
pharmacological
targeting
a
promising
therapeutic
strategy.
Frontiers in Aging Neuroscience,
Год журнала:
2022,
Номер
14
Опубликована: Фев. 16, 2022
Microglia-mediated
neuroinflammation
is
a
common
feature
of
neurodegenerative
diseases
such
as
Alzheimer's
disease
(AD),
Parkinson's
(PD),
amyotrophic
lateral
sclerosis
(ALS),
and
multiple
(MS).
Microglia
can
be
categorized
into
two
opposite
types:
classical
(M1)
or
alternative
(M2),
though
there's
continuum
different
intermediate
phenotypes
between
M1
M2,
microglia
transit
from
one
phenotype
to
another.
release
inflammatory
mediators
induce
inflammation
neurotoxicity,
while
M2
anti-inflammatory
neuroprotectivity.
considered
double-edged
sword,
performing
both
harmful
helpful
effects
in
diseases.
Previous
studies
showed
that
balancing
M1/M2
polarization
had
promising
therapeutic
prospect
We
suggest
shifting
may
significant
we
focus
on
the
modulation
especially
by
important
signal
pathways,
Journal of Hematology & Oncology,
Год журнала:
2021,
Номер
14(1)
Опубликована: Фев. 12, 2021
Mesenchymal
stromal
cells
(MSCs),
also
known
as
mesenchymal
stem
cells,
have
been
intensely
investigated
for
clinical
applications
within
the
last
decades.
However,
majority
of
registered
trials
applying
MSC
therapy
diverse
human
diseases
fallen
short
expectations,
despite
encouraging
pre-clinical
outcomes
in
varied
animal
disease
models.
This
can
be
attributable
to
inconsistent
criteria
MSCs
identity
across
studies
and
their
inherited
heterogeneity.
Nowadays,
with
emergence
advanced
biological
techniques
substantial
improvements
bio-engineered
materials,
strategies
developed
overcome
challenges
application.
Here
this
review,
we
will
discuss
major
therapies
application,
factors
impacting
diversity
MSCs,
potential
approaches
that
modify
products
highest
therapeutic
potential,
finally
usage
COVID-19
pandemic
disease.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2022,
Номер
9
Опубликована: Янв. 5, 2022
Exosomes,
a
nano-sized
subtype
of
extracellular
vesicles
secreted
from
almost
all
living
cells,
are
capable
transferring
cell-specific
constituents
the
source
cell
to
recipient
cell.
Cumulative
evidence
has
revealed
exosomes
play
an
irreplaceable
role
in
prognostic,
diagnostic,
and
even
therapeutic
aspects.
A
method
that
can
efficiently
provide
intact
pure
samples
is
first
step
both
exosome-based
liquid
biopsies
therapeutics.
Unfortunately,
common
exosomal
separation
techniques
suffer
operation
complexity,
time
consumption,
large
sample
volumes
low
purity,
posing
significant
challenges
for
downstream
analysis.
Efficient,
simple,
affordable
methods
isolate
crucial
carrying
out
relevant
researches.
In
last
decade,
emerging
technologies,
especially
microfluidic
chips,
have
proposed
superior
strategies
exosome
isolation
exhibited
fascinating
performances.
While
many
excellent
reviews
overviewed
various
methods,
compressive
review
including
updated/improved
indispensable.
Herein,
we
overview
properties,
biogenesis,
contents,
functions.
Then,
briefly
outline
conventional
technologies
discuss
clinical
applications
these
technologies.
Finally,
large-scale
GMP
production
engineered
open
up
future
perspectives
next-generation
Exo-devices
cancer
diagnosis
treatment.
Molecular Therapy,
Год журнала:
2020,
Номер
29(1), С. 13 - 31
Опубликована: Дек. 3, 2020
Plant
exosome-like
nanovesicles,
being
innately
replete
with
bioactive
lipids,
proteins,
RNA,
and
other
pharmacologically
active
molecules,
offer
unique
morphological
compositional
characteristics
as
natural
nanocarriers.
Furthermore,
their
compelling
physicochemical
traits
underpin
modulative
role
in
physiological
processes,
all
of
which
have
fostered
the
concept
that
these
nanovesicles
may
be
highly
proficient
development
next-generation
biotherapeutic
drug
delivery
nanoplatforms
to
meet
ever-stringent
demands
current
clinical
challenges.
This
review
systemically
deals
various
facets
plant
ranging
from
origin
isolation
identification
composition,
biological
functions,
cargo-loading
mechanisms.
Efforts
are
made
encompass
roles
by
elucidating
immunological
modulating,
anti-tumor,
regenerative,
anti-inflammatory
roles.
We
also
shed
light
on
re-engineering
into
robust,
innocuous,
non-immunogenic
nanovectors
for
through
multiple
stringent
hindrances
targeted
organs
such
intestine
brain.
Finally,
recent
advances
centered
around
along
new
insights
transdermal,
transmembrane
targeting
mechanisms
vesicles
elucidated.
expect
continuing
nanovesicle-based
therapeutic
will
promote
applications.
Cancer Discovery,
Год журнала:
2021,
Номер
11(4), С. 858 - 873
Опубликована: Апрель 1, 2021
Over
the
past
10
years,
circulating
tumor
cells
(CTC)
and
DNA
(ctDNA)
have
received
enormous
attention
as
new
biomarkers
subjects
of
translational
research.
Although
both
are
already
used
in
numerous
clinical
trials,
their
utility
is
still
under
investigation
with
promising
first
results.
Clinical
applications
include
early
cancer
detection,
improved
staging,
detection
relapse,
real-time
monitoring
therapeutic
efficacy,
targets
resistance
mechanisms.
Here,
we
propose
a
conceptual
framework
CTC
ctDNA
assays
point
out
current
challenges
research,
which
might
structure
this
dynamic
field
SIGNIFICANCE:
The
analysis
blood
for
CTCs
or
cell-free
nucleic
acids
called
"liquid
biopsy"
has
opened
avenues
diagnostics,
including
tumors,
risk
assessment
well
relapse
evolution
context
therapies.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
24(1), С. 449 - 449
Опубликована: Дек. 27, 2022
Regulated
cell
death
(RCD)
has
a
significant
impact
on
development,
tissue
homeostasis,
and
the
occurrence
of
various
diseases.
Among
different
forms
RCD,
ferroptosis
is
considered
as
type
reactive
oxygen
species
(ROS)-dependent
regulated
necrosis.
ROS
can
react
with
polyunsaturated
fatty
acids
(PUFAs)
lipid
(L)
membrane
via
formation
radical
L•
induce
peroxidation
to
form
L-ROS.
Ferroptosis
triggered
by
an
imbalance
between
hydroperoxide
(LOOH)
detoxification
iron-dependent
L-ROS
accumulation.
Intracellular
iron
accumulation
are
two
central
biochemical
events
leading
ferroptosis.
Organelles,
including
mitochondria
lysosomes
involved
in
regulation
metabolism
redox
In
this
review,
we
will
provide
overview
peroxidation,
well
key
components
ferroptotic
cascade.
The
main
mechanism
that
reduces
ability
glutathione
(GSH).
GSH,
tripeptide
includes
glutamic
acid,
cysteine,
glycine,
acts
antioxidant
substrate
peroxidase
4
(GPX4),
which
then
converted
into
oxidized
(GSSG).
Increasing
expression
GSH
inhibit
We
highlight
role
xc-
GSH-GPX4
pathway
regulate
system
xc-,
composed
subunit
solute
carrier
family
members
(SLC7A11
SLC3A2),
mediates
exchange
cystine
glutamate
across
plasma
synthesize
GSH.
Accumulating
evidence
indicates
requires
autophagy
machinery
for
its
execution.
Ferritinophagy
used
describe
removal
major
storage
protein
ferritin
machinery.
Nuclear
receptor
coactivator
(NCOA4)
cytosolic
bind
subsequent
degradation
ferritinophagy.
During
ferritinophagy,
stored
released
becomes
available
biosynthetic
pathways.
dysfunctional
response
implicated
variety
pathological
conditions.
inducers
or
inhibitors
targeting
redox-
metabolism-related
proteins
signal
transduction
have
been
developed.
simultaneous
detection
intracellular
extracellular
markers
may
help
diagnose
treat
diseases
related
damage.
Cell Death and Disease,
Год журнала:
2022,
Номер
13(7)
Опубликована: Июль 23, 2022
Abstract
The
growing
understanding
of
RNA
functions
and
their
crucial
roles
in
diseases
promotes
the
application
various
RNAs
to
selectively
function
on
hitherto
“undruggable”
proteins,
transcripts
genes,
thus
potentially
broadening
therapeutic
targets.
Several
RNA-based
medications
have
been
approved
for
clinical
use,
while
others
are
still
under
investigation
or
preclinical
trials.
Various
techniques
explored
promote
intracellular
trafficking
metabolic
stability,
despite
significant
challenges
developing
therapeutics.
In
this
review,
mechanisms
action,
challenges,
solutions,
therapeutics
comprehensively
summarized.